Humana Management

Management Kriterienprüfungen 2/4

Humana CEO ist Jim Rechtin , ernannt in Jan 2024, hat eine Amtszeit von weniger als ein Jahr. besitzt direkt 0.001% der Aktien des Unternehmens, im Wert von $247.45K . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 2.4 Jahre bzw. 4.1 Jahre.

Wichtige Informationen

Jim Rechtin

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	less than a year
Eigentum des Geschäftsführers	0.0008%
Durchschnittliche Amtszeit des Managements	2.4yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	4.1yrs

Jüngste Management Updates

Recent updates

Positive Sentiment Still Eludes Humana Inc. (NYSE:HUM) Following 30% Share Price Slump

Oct 03

Wall Street Lunch: Humana Shares Hit Hard

Oct 02

Humana's Falling Share Price Gives Investors An Opportunity

Sep 18

Humana (NYSE:HUM) Seems To Use Debt Quite Sensibly

Sep 15

Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Aug 19

Humana: Outlook Improving Ahead Of Q2 Earnings, 'Buy' Thesis Intact

Jul 24

Investors Interested In Humana Inc.'s (NYSE:HUM) Earnings

Jul 16

Humana: Medicare Advantage Will Never Be As Profitable As It Was

Jun 23

Humana (NYSE:HUM) Is Due To Pay A Dividend Of $0.885

Jun 20

Humana (NYSE:HUM) Will Pay A Dividend Of $0.885

Jun 06

Humana Is Set Up For Long-Term Success

Jun 05

Humana (NYSE:HUM) Has Affirmed Its Dividend Of $0.885

May 21

Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Apr 22

Here's Why Humana (NYSE:HUM) Can Manage Its Debt Responsibly

Apr 20

Humana: Where To Buy This

Apr 02

Humana: This Year's Drop Might Have Created A Buying Opportunity

Mar 19

Humana: A Golden Buying Opportunity As Fears Potentially Peaked

Feb 03

Humana: The $300 Level Could Get Taken Out In The Near Future

Jan 25

Humana: My Oh My, Another Strong Buy

Jan 14

Humana: Buy This Powerful Dividend Growth Stock In The New Year

Jan 02

Humana: Failed Merger And Other Reasons To Buy

Dec 11

Humana: Upgrade To Buy

Oct 06

Humana: Buy This Amazing Wealth Compounder Now, You'll Be Glad You Did

Sep 27

Humana: Mr. Market Got This One Right

Aug 03

Humana: Recent Selloff Might Present A Buying Opportunity

Jul 13

Humana: Rising Medical Costs Should Be Temporary

Jun 28

Humana: Margin Expansion Supported By Growing Memberships

Jun 12

Geschäftsführer

Jim Rechtin (53 yo)

less than a year

Amtszeit

Mr. James A. Rechtin, also known as Jim, MBA, served as COO of Humana Inc. since January 08, 2024 until July 01, 2024 and serves as its President since January 08, 2024 and also serves as its Chief Executi...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Susan Diamond	Chief Financial Officer	3.6yrs	US$4.73m	0.0081% $ 2.5m
Joseph Ventura	Chief Legal Officer	5.9yrs	US$3.10m	0.0066% $ 2.0m
Bruce Broussard	Strategic Advisor	less than a year	US$16.33m	0.073% $ 22.4m
George Renaudin	President of Medicare & Medicaid	1.9yrs	US$3.11m	0.0038% $ 1.2m
Sanjay Shetty	President of CenterWell	1.8yrs	US$4.58m	0.00065% $ 198.6k
James Rechtin	President	less than a year	keine Daten	0.00081% $ 247.5k
John-Paul Felter	Senior VP	2.4yrs	keine Daten	0.00047% $ 143.6k
Eric Tagliere	Senior VP & CTO	1.1yrs	keine Daten	keine Daten
Samir Deshpande	Chief Information Officer	4yrs	keine Daten	0.011% $ 3.3m
Timothy Huval	Chief Administrative Officer	5.5yrs	US$3.73m	0.0067% $ 2.0m
Lisa Stoner	Vice President of Investor Relations	no data	keine Daten	keine Daten
Vishal Agrawal	Chief Strategy & Corporate Development Officer	6.1yrs	keine Daten	0.0095% $ 2.9m

2.4yrs

Durchschnittliche Betriebszugehörigkeit

51.5yo

Durchschnittliches Alter

Erfahrenes Management: HUMDas Führungsteam des Unternehmens gilt als erfahren (2.4 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
James Rechtin	President	less than a year	keine Daten	0.00081% $ 247.5k
Kurt Hilzinger	Independent Chairman of the Board	21.5yrs	US$601.30k	0.016% $ 4.9m
Karen Katz	Independent Director	5.3yrs	US$346.55k	0.00049% $ 149.7k
Frank D'Amelio	Independent Director	21.3yrs	US$363.55k	0.017% $ 5.2m
Jorge Mesquita	Independent Director	3.9yrs	US$351.59k	0.0018% $ 543.8k
Brad Smith	Independent Director	2.3yrs	US$311.07k	0.00032% $ 97.8k
Wayne Frederick	Independent Director	4.9yrs	US$364.87k	0.00037% $ 113.0k
David Feinberg	Independent Director	2.8yrs	US$321.52k	0.00037% $ 113.0k
Marcy Klevorn	Independent Director	3.9yrs	US$351.94k	0.00036% $ 110.0k
John Garratt	Independent Director	4.9yrs	US$326.03k	0.0010% $ 317.7k
RaQuel Bono	Independent Director	4.3yrs	US$345.03k	0.00033% $ 100.8k
Gordon Smith	Independent Director	less than a year	keine Daten	keine Daten

4.1yrs

Durchschnittliche Betriebszugehörigkeit

62yo

Durchschnittliches Alter

Erfahrener Vorstand: HUMDie Vorstandsmitglieder gelten als erfahren (4.1 Jahre durchschnittliche Amtszeit).

Unternehmensanalyse und Finanzdaten Status

Daten	Zuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse	2025/01/02 01:39
Aktienkurs zum Tagesende	2024/12/31 00:00
Gewinne	2024/09/30
Jährliche Einnahmen	2023/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

Paket	Daten	Zeitrahmen	Beispiel US-Quelle ^*
Finanzdaten des Unternehmens	10 Jahre	Gewinn- und Verlustrechnung Kapitalflussrechnung Bilanz	SEC-Formular 10-K SEC-Formular 10-Q
Konsensschätzungen der Analysten	+3 Jahre	Finanzielle Vorausschau Kursziele der Analysten	Analysten Research Berichte Blue Matrix
Marktpreise	30 Jahre	Aktienkurse Dividenden, Splits und Aktionen	ICE-Marktdaten SEC-Formular S-1
Eigentümerschaft	10 Jahre	Top-Aktionäre Insiderhandel	SEC-Formular 4 SEC-Formular 13D
Verwaltung	10 Jahre	Das Führungsteam Direktorium	SEC-Formular 10-K SEC-Formular DEF 14A
Wichtige Entwicklungen	10 Jahre	Ankündigungen des Unternehmens	SEC-Formular 8-K

^* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie hier mehr.

Analysemodell und Schneeflocke

Einzelheiten zum Analysemodell, das zur Erstellung dieses Berichts verwendet wurde, finden Sie auf unserer Github-Seite. Wir haben auch Anleitungen zur Verwendung unserer Berichte und Tutorials auf Youtube.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf .

Analysten-Quellen

Humana Inc. wird von 51 Analysten beobachtet. 20 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

Analyst	Einrichtung
David Toung	Argus Research Company
Hua Ha	Baird
Ishan Majumdar	Baptista Research

Humana Management

Management Kriterienprüfungen 2/4

Wichtige Informationen

Jüngste Management Updates

Humana Inc. Announces Board Changes

Humana Inc. Announces CFO Changes

Humana Inc. Appoints Michelle O'hara as Chief Human Resources Officer, Effective January 1, 2025

Humana Elects Gordon Smith to Board of Directors

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Recent updates

Upcoming dividend of US$0.89 per share

Humana Inc. Announces Board Changes

Humana, Cigna Plunge On Trump's Latest Promise: A Potential Buying Opportunity?

Investor sentiment deteriorates as stock falls 18%

Humana: Medicare Advantage Is Just A Short-Term Problem

Humana Inc. Announces CFO Changes

Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Humana Inc. Appoints Michelle O'hara as Chief Human Resources Officer, Effective January 1, 2025

Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Humana - Q3 Earnings Review: The Medicare Advantage Madness May Finally Be Over

Humana Inc. Updates Earnings Guidance for the Year Ending December 31, 2024

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Humana (NYSE:HUM) Will Pay A Dividend Of $0.885

Second quarter dividend of US$0.89 announced

Humana Inc. Declares Payment of Quarterly Dividend to Stockholders, Payable on January 31, 2025

Humana Elects Gordon Smith to Board of Directors

Price target decreased by 10% to US$352

Positive Sentiment Still Eludes Humana Inc. (NYSE:HUM) Following 30% Share Price Slump

Investor sentiment deteriorates as stock falls 21%

Wall Street Lunch: Humana Shares Hit Hard

Humana Inc. to Report Q3, 2024 Results on Oct 30, 2024

Upcoming dividend of US$0.89 per share

Humana's Falling Share Price Gives Investors An Opportunity

Humana (NYSE:HUM) Seems To Use Debt Quite Sensibly

Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Second quarter dividend of US$0.89 announced

Humana Settles for $90 Million Groundbreaking False Claims Act Case Alleging Medicare Part D Prescription Drug Program Fraud

Humana Inc. Declares Cash Dividend, Payable on October 25, 2024

Second quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Humana: Outlook Improving Ahead Of Q2 Earnings, 'Buy' Thesis Intact

Investors Interested In Humana Inc.'s (NYSE:HUM) Earnings

Humana Inc. to Report Q2, 2024 Results on Jul 31, 2024

Humana: Medicare Advantage Will Never Be As Profitable As It Was

Humana (NYSE:HUM) Is Due To Pay A Dividend Of $0.885

Humana (NYSE:HUM) Will Pay A Dividend Of $0.885

Gainey Mckenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Humana, Inc

Humana Is Set Up For Long-Term Success

Humana (NYSE:HUM) Has Affirmed Its Dividend Of $0.885

First quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Dividend of US$0.89 announced

Here's Why Humana (NYSE:HUM) Can Manage Its Debt Responsibly

Humana Inc. Declares Cash Dividend, Payable on July 26, 2024

Humana Inc. to Report Q1, 2024 Results on Apr 24, 2024

Humana: Where To Buy This

Humana: This Year's Drop Might Have Created A Buying Opportunity

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc. Declares Cash Dividend, Payable on April 26, 2024

Humana: A Golden Buying Opportunity As Fears Potentially Peaked

Humana Inc. Provides Earnings Guidance for 2024

Humana: The $300 Level Could Get Taken Out In The Near Future

Humana Announces Limited Layoffs

Humana: My Oh My, Another Strong Buy

Humana: Buy This Powerful Dividend Growth Stock In The New Year

Upcoming dividend of US$0.89 per share at 0.8% yield

President exercised options and sold US$1.3m worth of stock

Humana: Failed Merger And Other Reasons To Buy

Cigna Reportedly Ends Humana Merger Talks

Cigna, Humana Reportedly in Talks for Merger

Humana Inc. Declares Cash Dividend, Payable on January 26, 2024

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana Inc. Announces Management Changes

Humana Inc. to Report Q3, 2023 Results on Nov 01, 2023

Humana: Upgrade To Buy

Humana Inc. (NYSE:HUM) agreed to acquire Senior-focused primary care centers in Texas and Nevada of Cano Health, LLC for $66.7 million.

Humana: Buy This Amazing Wealth Compounder Now, You'll Be Glad You Did